Pancreatic Cancer News and Research

RSS
Pancreatic cancer is the fourth leading cause of all cancer deaths in the United States and the third leading cause of cancer deaths in individuals ages 40 to 60. Approximately 37,000 Americans are diagnosed with pancreatic cancer each year, and, each year, approximately the same number die from it. Often, pancreatic cancer is found too late for surgical intervention, and chemotherapy and radiation treatments have little effect.
New findings offer promising druggable target to root out metastatic pancreatic cancer

New findings offer promising druggable target to root out metastatic pancreatic cancer

Dream Team plans to stop pancreatic cancer before symptoms occur

Dream Team plans to stop pancreatic cancer before symptoms occur

Scientists uncover surprising molecular link in critical cellular growth pathway

Scientists uncover surprising molecular link in critical cellular growth pathway

Investigating new cancer therapy candidates with live-cell imaging

Investigating new cancer therapy candidates with live-cell imaging

TGen awarded $2.5 million SU2C grant to test new method of treating pancreatic cancer

TGen awarded $2.5 million SU2C grant to test new method of treating pancreatic cancer

Globus to build new protected cancer research networks for enhancing data security

Globus to build new protected cancer research networks for enhancing data security

Salk scientists receive $2.5 million funding to conduct pancreatic cancer clinical study

Salk scientists receive $2.5 million funding to conduct pancreatic cancer clinical study

Cholesterol byproduct acts on specific immune cells to facilitate breast cancer spread

Cholesterol byproduct acts on specific immune cells to facilitate breast cancer spread

Research finds higher rates of cancer in world's ‘better’ countries

Research finds higher rates of cancer in world's ‘better’ countries

Researchers discover mutation that amplifies capabilities of tumor-suppressor protein

Researchers discover mutation that amplifies capabilities of tumor-suppressor protein

New research can help develop better chemotherapy treatments for pancreatic cancer

New research can help develop better chemotherapy treatments for pancreatic cancer

Bariatric surgery linked to reduced risk of cancer for severely obese patients

Bariatric surgery linked to reduced risk of cancer for severely obese patients

Rapid, sensitive genetic test successfully detects some aggressive types of pancreatic cancer

Rapid, sensitive genetic test successfully detects some aggressive types of pancreatic cancer

UTSW receives $34 million CPRIT award for cancer research and faculty recruitment

UTSW receives $34 million CPRIT award for cancer research and faculty recruitment

Research shows how bacteria inactivate common drug used to treat cancers

Research shows how bacteria inactivate common drug used to treat cancers

Clinical trial evaluates key-hole and open surgery in pancreatic cancer patients

Clinical trial evaluates key-hole and open surgery in pancreatic cancer patients

Controlling zinc transporter levels could be effective plan to combat pancreatic cancer, other diseases

Controlling zinc transporter levels could be effective plan to combat pancreatic cancer, other diseases

Blood tumor markers could be useful in monitoring therapeutic outcomes for lung cancer patients

Blood tumor markers could be useful in monitoring therapeutic outcomes for lung cancer patients

Combined DNA and protein 'liquid biopsy' more accurate in identifying early-stage pancreatic cancer

Combined DNA and protein 'liquid biopsy' more accurate in identifying early-stage pancreatic cancer

Smartphone app could be used to screen for pancreatic cancer

Smartphone app could be used to screen for pancreatic cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.